General MedicationsINTRAVENOUSStandard
PRALATREXATE
PRALATREXATE
Standard Dose
20MG/ML (20MG/ML)
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview PRALATREXATE is listed in Drugs@FDA under application 206183 (ANDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient PRALATREXATE Form and strength SOLUTION;INTRAVENOUS - 20MG/ML (20MG/ML) Sponsor DR REDDYS Submission history Latest submission status date: 2025-03-10 00:00:00.
Structured Monograph
Clinical summary
Approval overview PRALATREXATE is listed in Drugs@FDA under application 206183 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient PRALATREXATE Form and strength SOLUTION;INTRAVENOUS - 20MG/ML (20MG/ML) Sponsor DR REDDYS Submission history Latest submission status date: 2025-03-10 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.